Evolutionary Nephrology.
Evolutionary Nephrology.
复制标题
进化肾脏科。
DOI:
10.1016/j.ekir.2017.01.012
复制
发表时间:
2017-05
影响因子:
6
通讯作者:
Chevalier RL
中科院分区:
文献类型:
--
作者:
Chevalier RL
Progressive kidney disease follows nephron loss, hyperfiltration, and incomplete repair, a process described as “maladaptive.” In the past 20 years, a new discipline has emerged that expands research horizons: evolutionary medicine. In contrast to physiologic (homeostatic) adaptation, evolutionary adaptation is the result of reproductive success that reflects natural selection. Evolutionary explanations for physiologically maladaptive responses can emerge from mismatch of the phenotype with environment or from evolutionary tradeoffs. Evolutionary adaptation to a terrestrial environment resulted in a vulnerable energy-consuming renal tubule and a hypoxic, hyperosmolar microenvironment. Natural selection favors successful energy investment strategy: energy is allocated to maintenance of nephron integrity through reproductive years, but this declines with increasing senescence after ∼40 years of age. Risk factors for chronic kidney disease include restricted fetal growth or preterm birth (life history tradeoff resulting in fewer nephrons), evolutionary selection for APOL1 mutations (which provide resistance to trypanosome infection, a tradeoff), and modern life experience (Western diet mismatch leading to diabetes and hypertension). Current advances in genomics, epigenetics, and developmental biology have revealed proximate causes of kidney disease, but attempts to slow kidney disease remain elusive. Evolutionary medicine provides a complementary approach by addressing ultimate causes of kidney disease. Marked variation in nephron number at birth, nephron heterogeneity, and changing susceptibility to kidney injury throughout the life history are the result of evolutionary processes. Combined application of molecular genetics, evolutionary developmental biology (evo-devo), developmental programming, and life history theory may yield new strategies for prevention and treatment of chronic kidney disease.
登录
查看更多内容
影响因子:
158.5
作者:
BRENNER, BM;MEYER, TW;HOSTETTER, TH
通讯作者:
HOSTETTER, TH
影响因子:
13.6
作者:
Arcolino, Fanny Oliveira;Zia, Silvia;Levtchenko, Elena
通讯作者:
Levtchenko, Elena
影响因子:
11.1
作者:
Barker, D. J. P.
通讯作者:
Barker, D. J. P.
DOI:
10.1126/science.1226467
发表时间:
2012-11-02
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Baudisch A;Vaupel JW
通讯作者:
Vaupel JW
DOI:
10.1152/ajprenal.00092.2014
发表时间:
2014-06-01
影响因子:
4.2
作者:
Beeman, Scott C.;Cullen-McEwen, Luise A.;Bennett, Kevin M.
通讯作者:
Bennett, Kevin M.